Matt Lipscomb is the founder of DMC Biotechnologies. DMC Biotechnologies has raised $50M in total funding. Latest round: Series B. Backed by SCG.
Matt Lipscomb is the co-founder and CEO of DMC Biotechnologies, a Boulder-based biotech company specializing in sustainable bio-based chemicals through precision fermentation. Under his leadership, the company has raised over $50 million in capital and employs over 40 people. He holds a doctorate and is recognized for integrating sustainable chemistry with business strategy.
Full founder directory · Investor directory · Company funding database · Fundraising library